Sir Cliff Richard reveals prostate cancer treatment
Sir Cliff Richard announced that he was treated for prostate cancer.
The 85-year-old singer said that the cancer was discovered recently when he went for a check-up for a tour, but it was caught early and did not spread.
“I was going to Australia and New Zealand and the organizer said, ‘We need your insurance so you need to be checked for something.’ They found out I had prostate cancer,” he told ITV’s Good Morning Britain.
“The good luck was that it wasn’t too old, and the other thing was that it hadn’t metastasized. It hadn’t moved, nothing had happened to the bones or anything like that.”
Sir Cliff was speaking to journalist Dermot Murnaghan in June. have stage four prostate cancer.
The singer said: “I don’t know if he will come back. We cannot say such things, but I definitely believe that we need to go there, get tested, get checked.”
Sir Cliff also said he wanted to work with the King to improve cancer screening for men. The King spoke last week He talked about his own cancer treatment and touched upon the importance of check-ups to detect cancer at an early stage.
The musician called the lack of a national release schedule “absolutely ridiculous.”
“We have governments to look after our country and the people who live in that country, so I don’t understand how you can say, ‘We can do this, we can do that, but we’re not doing it for these people,'” he said.
“We all deserve to have the same ability to get tested and start treatment really early.
“It seems to me that I’ve only been in contact with cancer for a year, but every time I talk to someone this topic comes up and that’s why I think our government should listen to us.”
Sir Cliff is known for decades of hit songs such as The Young Ones, We Don’t Talk Anymore and Summer Holiday.
Last month, the National Screening Committee, which advises governments across the UK, said a prostate cancer screening program for all men in the UK was not justified.
They say only men with specific genetic mutations that lead to more aggressive tumors should be eligible.
A three-month consultation began at the end of November before the committee met again and made its final recommendations to ministers in England, Wales, Northern Ireland and Scotland; Each of these ministers will make their own decisions on prostate screening.
